With 10 cases in 2025, Guinea worm could be the second disease ever eradicated. Here is what makes disease eradication ...

Unlike traditional drugs that bind directly to a protein’s active site, allosteric modulators act at separate regulatory sites, allowing them to fine-tune biological activity and act more like a ...

New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

As numerous trends are currently shaping what is an eventful year for the biotech industry, we have compiled a list of the top European biotech companies that have received sizable seed funding in the ...

What if the key to a greener future wasn’t in high-tech gadgets or sweeping legislation, but in mushrooms, plant cells, and even food waste? As the world scrambles to combat climate change and reduce ...

There hasn’t been a lot of hair loss treatment progress in the last twenty years. However several biotech companies are hot on the case and are getting tantalizingly close to the breakthrough that ...

Robert received his PhD in Biochemistry from the Leiden University Medical Center where he studied oncogenic cell transformation in the lab of Prof. van de Eb. He subsequently moved to Stanford ...

The J.P. Morgan Healthcare Summit (JPM) serves as the world’s largest healthcare conference where healthcare professionals, scientists, and innovators meet with investors to set the agenda for the ...

Genome Valley, the 2,000-acre life sciences cluster just outside Hyderabad, is at the heart of Telangana’s claim to being the “vaccine capital of the world.” Data show the region produces around ...

Since 2020, the Qatar Investment Authority (QIA) has been taking part in important biotech fundings reaching its peak in 2021 and remaining strong in 2023. They recently led a $250 million round in ...

This webinar is intended for scientists, computational chemists, and R&D leaders interested in practical strategies for integrating LLMs and agentic workflows into modern drug discovery programs.